TSHA - Taysha Gene Therapies Inc.

Healthcare - Sector
Coverage Rating Distribution Performance Price Targets & Ratings Chart

TSHA is currently covered by 11 analysts with average potential upside of $14.29 (213.62%) backed by 5 price targets and 28 ratings. Documented since 19-Oct-2020. Analyst's average stock valuation to be materialised ratio is 4.76% with an average time for price targets to be met of 13.14 days.

Most recent stock forecast was given by YUN ZHONG from BTIG on 02-Feb-2023.

Highest price target for TSHA is 26, Lowest price target is 1, average price target is 13.5.

Best performing analysts who are covering TSHA - Taysha Gene Therapies Inc.:

Salveen Richter Silvan Tuerkcan Laura Chico Gbola Amusa Gil Blum Geulah Livshits Yun Zhong

Currently, out of the existing stock ratings of TSHA - 24 which are a Buy (96%), 1 which are a Hold (4%)

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

25

1 months 23 days ago

0/2 (0%)

$18.47 (182.70%)

Buy

4

$3.32 (488.24%)

36

1 months 24 days ago

0/7 (0%)

$23.57 (285.45%)

Buy

6

$5.32 (782.35%)

1 months 24 days ago

0/1 (0%)

$4.79 (395.87%)

Buy

6

$5.32 (782.35%)

1 months 24 days ago

0/1 (0%)

$4.79 (395.87%)

Hold

3

$2.32 (341.18%)

4 months 16 days ago

1/3 (33.33%)

$7.81 (52.75%)

92

Show more analysts

What is TSHA(Taysha Gene Therapies Inc.) average time for price targets to be met?

On average it took 13.14 days on average for the stock forecasts to be realized with a an average price target met ratio 4.76

Which analyst has the current highest performing score on TSHA(Taysha Gene Therapies Inc.) with a proven track record?

SALVEEN RICHTER